
Company valuation, historical trends, and peer comparisons.
According to Bayer AG’s latest financial reports and current stock price. The company's current Enterprise Value is 87.43B. This represents a change of 23.94% compared to the average of 70.54B of the last 4 quarters.
The mean historical Enterprise Value of Bayer AG over the last ten years is 83.86B. The current 87.43B Enterprise Value has changed 4.26% with respect to the historical average. Over the past ten years (40 quarters), BAYRY's Enterprise Value was at its highest in in the June 2018 quarter at 133.54B. The Enterprise Value was at its lowest in in the December 2024 quarter at 53.52B.
Average
83.86B
Median
84.31B
Minimum
53.52B
Maximum
107.17B
Discovering the peaks and valleys of Bayer AG Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 25.42%
Maximum Annual Enterprise Value = 107.17B
Minimum Annual Increase = -25.58%
Minimum Annual Enterprise Value = 53.52B
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 67.13B | 25.42% |
| 2024 | 53.52B | -25.58% |
| 2023 | 71.92B | -14.33% |
| 2022 | 83.96B | 3.47% |
| 2021 | 81.14B | -4.16% |
| 2020 | 84.67B | -21.00% |
| 2019 | 107.17B | 14.17% |
| 2018 | 93.87B | -2.55% |
| 2017 | 96.33B | -2.59% |
| 2016 | 98.89B | -12.26% |
The current Enterprise Value of Bayer AG (BAYRY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
64.19B
5-year avg
71.53B
10-year avg
83.86B
Bayer AG’s Enterprise Value is less than Roche Holding AG (299.56B), less than Merck & Co., Inc. (415.14B), less than Sanofi (117.98B), less than AstraZeneca PLC (319.58B), less than Novartis AG (351.19B), less than Johnson & Johnson (692.93B), less than Eli Lilly and Company (1.38T), less than AbbVie Inc. (591.13B), less than Amgen Inc. (299.50B), less than Pfizer Inc. (236.34B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 299.56B | $388.50B | |
| 415.14B | $370.91B | |
| 117.98B | $113.74B | |
| 319.58B | $293.13B | |
| 351.19B | $311.59B | |
| 692.93B | $665.19B | |
| 1.38T | $1.33T | |
| 591.13B | $521.00B | |
| 299.50B | $258.68B | |
| 236.34B | $175.49B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bayer AG using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Bayer AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Bayer AG's Enterprise Value?
What is the highest Enterprise Value for Bayer AG (BAYRY)?
What is the 3-year average Enterprise Value for Bayer AG (BAYRY)?
What is the 5-year average Enterprise Value for Bayer AG (BAYRY)?
How does the current Enterprise Value for Bayer AG (BAYRY) compare to its historical average?